T1 mapping as a quantitative imaging biomarker for diagnosing cervical cancer: a comparison with diffusion kurtosis imaging.

"Declarations Ethics approval and consent to participateThis was a prospectively single-center study approved by the Institutional Review Board of the First Affiliated Hospital of Zhengzhou University (2019KY-289). All methods were carried out in accordance with relevant guidelines and regulations, and written informed consent was obtained from all participants. Consent for publicationNot applicable. Competing interestsThree of the authors of this manuscript (Robert Grimm, Feifei Qu and Jinxia Zhu) are employees of Siemens Healthcare, whose products or services may be related to the subject matter of the article. The remaining authors declare no relationships with any companies. Competing interests Three of the authors of this manuscript (Robert Grimm, Feifei Qu and Jinxia Zhu) are employees of Siemens Healthcare, whose products or services may be related to the subject matter of the article. The remaining authors declare no relationships with any companies."

"Funding This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors."